Is nebulized hypertonic saline solution treatment with or without beta-2 agonists recommended for all hospitalized patients with bronchiolitis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18902730
Cited by: 0

Abstract

Nebulized hypertonic saline, with or without beta-2 agonists, is not universally recommended for all hospitalized patients with bronchiolitis, as current evidence is inconclusive and of low certainty.

Fields of Study & Subjects

Respiratory viral infections research Pediatric health and respiratory diseases Pneumonia and Respiratory Infections

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
7 March 2026
Language
EN